8-K Announcements
6Material company update
Apr 21, 2026·SEC
Material company update
Mar 9, 2026·SEC
Material company update
Mar 2, 2026·SEC
UnitedHealth Group Incorporated(UNH)Earnings, Financials & Key Ratios
UNH•NYSE•Insurance & Managed Care
$363.87
$330.28B mkt cap·27.5× P/E·Price updated May 6, 2026
AboutUnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.Show more
- Revenue$447.57B+11.8%
- Combined Ratio95.76%+4.2%
- Net Income$12.06B-16.3%
- Return on Equity11.8%-17.4%
- Medical Cost Ratio81.47%+4.9%
- Operating Margin4.24%-47.5%
- Net Margin2.69%-25.1%
- ROA3.97%-21.2%
- Equity / Assets32.85%-4.5%
- Book Value per Share111.76+1.2%
- Tangible BV/Share-32.17-9.0%
- Debt/Equity0.77+2.8%
UNH Key Insights
UnitedHealth Group Incorporated (UNH) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Dividend Aristocrat: 25 years of consecutive increases
- ✓Good 3Y average ROE of 16.8%
- ✓Healthy dividend yield of 2.4%
- ✓Share count reduced 2.0% through buybacks
✗Weaknesses
- ✗High loss ratio of 81.5%
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
UNH Price & Volume
UnitedHealth Group Incorporated (UNH) stock price & volume — 10-year historical chart
Loading chart...
UNH Growth Metrics
UnitedHealth Group Incorporated (UNH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years11.04%
5 Years11.72%
3 Years11.35%
TTM9.67%
Profit CAGR
10 Years7.57%
5 Years-4.78%
3 Years-15.69%
TTM-45.52%
EPS CAGR
10 Years8.21%
5 Years-3.77%
3 Years-14.52%
TTM-44.55%
Return on Capital
10 Years17.79%
5 Years16.98%
3 Years15.59%
Last Year9.75%
UNH Recent Earnings
UnitedHealth Group Incorporated (UNH) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 10/12 qtrs (83%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
Apr 21, 2026EPS
$7.23
Est $6.58
+9.9%
Revenue
$111.7B
Est $109.4B
+2.1%
Q1 2026
Jan 27, 2026EPS
$2.11
Est $2.10
+0.5%
Revenue
$113.2B
Est $113.8B
-0.5%
Q4 2025
Oct 28, 2025EPS
$2.92
Est $2.80
+4.3%
Revenue
$113.2B
Est $113.0B
+0.1%
Q3 2025
Jul 29, 2025EPS
$4.08
Est $4.45
-8.3%
Revenue
$111.6B
Est $111.5B
+0.1%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 21, 2026 | $7.23vs $6.58+9.9% | $111.7Bvs $109.4B+2.1% |
| Q1 2026 | Jan 27, 2026 | $2.11vs $2.10+0.5% | $113.2Bvs $113.8B-0.5% |
| Q4 2025 | Oct 28, 2025 | $2.92vs $2.80+4.3% | $113.2Bvs $113.0B+0.1% |
| Q3 2025 | Jul 29, 2025 | $4.08vs $4.45-8.3% | $111.6Bvs $111.5B+0.1% |
Based on last 12 quarters of dataView full earnings history →
UNH Peer Comparison
UnitedHealth Group Incorporated (UNH) competitors in Vertically Integrated Payer-PBM Platforms — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 CVS | 102.56B | 80.69 | 58.05 | 7.85% | 0.44% | 2.35% | 7.61% | 1.24 |
 ELV | 80.15B | 369.07 | 14.69 | 12.62% | 2.62% | 11.92% | 3.96% | 0.75 |
 CI | 72.68B | 275.66 | 12.43 | 11.26% | 2.26% | 15.08% | 11.54% | 0.75 |
 HUM | 28.76B | 239.53 | 24.34 | 10.06% | 0.82% | 6.17% | 1.3% | 0.73 |
 CNC | 26.15B | 52.97 | -3.89 | 19.44% | -3.25% | -28.6% | 16.52% | 0.94 |
 MOH | 10.01B | 192.17 | 21.54 | 11.75% | 0.42% | 4.44% | 0.97 | |
 HCSG | 1.56B | 21.73 | 26.83 | 7.08% | 3.21% | 11.83% | 8.94% | 0.05 |
 OSCR | 4.71B | 17.94 | -10.62 | 27.5% | -3.79% | -45.19% | 22.49% | 0.44 |
Compare UNH vs Peers
UnitedHealth Group Incorporated (UNH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
UNH Income Statement
UnitedHealth Group Incorporated (UNH) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 201.16B | 226.25B | 242.16B | 257.14B | 287.6B | 324.16B | 371.62B | 400.28B | 447.57B | 449.71B |
| Revenue Growth % | 8.83% | 12.47% | 7.03% | 6.19% | 11.84% | 12.71% | 14.64% | 7.71% | 11.81% | 9.67% |
| Medical Costs & Claims | 154.15B | 172.4B | 184.56B | 190.14B | 217.94B | 244.54B | 280.66B | 310.88B | 364.65B | 365.16B |
| Medical Cost Ratio % | 76.63% | 76.2% | 76.21% | 73.94% | 75.78% | 75.44% | 75.52% | 77.67% | 81.47% | 81.2% |
| Gross Profit | 47.01B▲ 0% | 53.85B▲ 14.5% | 57.6B▲ 7.0% | 67B▲ 16.3% | 69.65B▲ 4.0% | 79.62B▲ 14.3% | 90.96B▲ 14.2% | 89.4B▼ 1.7% | 82.92B▼ 7.3% | 84.55B▲ 0% |
| Gross Margin % | 23.37% | 23.8% | 23.79% | 26.06% | 24.22% | 24.56% | 24.48% | 22.33% | 18.53% | 18.8% |
| Gross Profit Growth % | 8.36% | 14.54% | 6.97% | 16.32% | 3.96% | 14.31% | 14.24% | -1.71% | -7.25% | - |
| Operating Expenses | 31.8B | 36.5B | 37.91B | 44.59B | 45.68B | 51.18B | 58.6B | 57.11B | 63.95B | 65.72B |
| OpEx / Revenue % | 15.81% | 16.13% | 15.66% | 17.34% | 15.88% | 15.79% | 15.77% | 14.27% | 14.29% | 14.61% |
| Depreciation & Amortization | 2.25B | 2.43B | 2.72B | 2.89B | 3.1B | 3.4B | 3.97B | 4.1B | 4.36B | 4.33B |
| Combined Ratio % | 92.44% | 92.33% | 91.87% | 91.29% | 91.67% | 91.23% | 91.29% | 91.93% | 95.76% | 95.81% |
| Operating Income | 15.21B▲ 0% | 17.34B▲ 14.0% | 19.68B▲ 13.5% | 22.41B▲ 13.8% | 23.97B▲ 7.0% | 28.43B▲ 18.6% | 32.36B▲ 13.8% | 32.29B▼ 0.2% | 18.96B▼ 41.3% | 18.84B▲ 0% |
| Operating Margin % | 7.56% | 7.67% | 8.13% | 8.71% | 8.33% | 8.77% | 8.71% | 8.07% | 4.24% | 4.19% |
| Operating Income Growth % | 17.63% | 14.04% | 13.5% | 13.82% | 6.98% | 18.63% | 13.8% | -0.22% | -41.26% | - |
| EBITDA | 17.45B | 19.77B | 22.41B | 25.3B | 27.07B | 31.84B | 36.33B | 36.39B | 23.32B | 23.16B |
| EBITDA Margin % | 8.68% | 8.74% | 9.25% | 9.84% | 9.41% | 9.82% | 9.78% | 9.09% | 5.21% | 5.15% |
| Interest Expense | 1.19B | 1.4B | 1.7B | 1.66B | 1.66B | 2.09B | 3.25B | 3.91B | 4B | 3.96B |
| Non-Operating Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.31B | 265M | 178M |
| Pretax Income | 14.02B▲ 0% | 15.94B▲ 13.7% | 17.98B▲ 12.8% | 20.74B▲ 15.4% | 22.31B▲ 7.6% | 26.34B▲ 18.1% | 29.11B▲ 10.5% | 20.07B▼ 31.1% | 14.7B▼ 26.8% | 14.55B▲ 0% |
| Pretax Margin % | 6.97% | 7.05% | 7.43% | 8.07% | 7.76% | 8.13% | 7.83% | 5.01% | 3.28% | 3.24% |
| Income Tax | 3.2B | 3.56B | 3.74B | 4.97B | 4.58B | 5.7B | 5.97B | 4.83B | 1.89B | 1.74B |
| Effective Tax Rate % | 22.82% | 22.34% | 20.81% | 23.98% | 20.52% | 21.65% | 20.5% | 24.06% | 12.86% | 11.96% |
| Net Income | 10.56B▲ 0% | 11.99B▲ 13.5% | 13.84B▲ 15.5% | 15.4B▲ 11.3% | 17.29B▲ 12.2% | 20.12B▲ 16.4% | 22.38B▲ 11.2% | 14.4B▼ 35.6% | 12.06B▼ 16.3% | 12.04B▲ 0% |
| Net Margin % | 5.25% | 5.3% | 5.71% | 5.99% | 6.01% | 6.21% | 6.02% | 3.6% | 2.69% | 2.68% |
| Net Income Growth % | 50.46% | 13.53% | 15.46% | 11.3% | 12.22% | 16.4% | 11.24% | -35.64% | -16.31% | -45.52% |
| EPS (Diluted) | 10.72▲ 0% | 12.19▲ 13.7% | 14.33▲ 17.6% | 16.03▲ 11.9% | 18.08▲ 12.8% | 21.18▲ 17.1% | 23.86▲ 12.7% | 15.51▼ 35.0% | 13.23▼ 14.7% | 13.24▲ 0% |
| EPS Growth % | 47.86% | 13.71% | 17.56% | 11.86% | 12.79% | 17.15% | 12.65% | -35% | -14.7% | -44.55% |
| EPS (Basic) | 10.95 | 12.45 | 14.55 | 16.28 | 18.33 | 21.54 | 24.12 | 15.64 | 13.23 | - |
| Diluted Shares Outstanding | 985M | 983M | 966M | 961M | 956M | 950M | 938M | 929M | 910M | 910M |
UNH Balance Sheet
UnitedHealth Group Incorporated (UNH) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 139.06B | 152.22B | 173.89B | 197.29B | 212.21B | 245.71B | 273.72B | 298.28B | 309.58B | 312.64B |
| Asset Growth % | 13.35% | 9.47% | 14.23% | 13.46% | 7.56% | 15.79% | 11.4% | 8.97% | 3.79% | 17.91% |
| Total Investment Assets | 31.85B | 35.97B | 40.47B | 44.1B | 45.65B | 48.27B | 4.2B | 56.16B | 58.01B | 4M |
| Long-Term Investments | 28.34B | 32.51B | 37.21B | 41.24B | 43.11B | 43.73B | 0 | 52.35B | 54.25B | 216.5B |
| Short-Term Investments | 3.51B | 3.46B | 3.26B | 2.86B | 2.53B | 4.55B | 4.2B | 3.8B | 3.76B | 3.23B |
| Total Current Assets | 37.08B | 38.69B | 42.63B | 53.72B | 61.76B | 69.07B | 78.44B | 85.78B | 90.58B | 91.13B |
| Cash & Equivalents | 11.98B | 10.87B | 10.98B | 16.92B | 21.38B | 23.36B | 25.43B | 25.31B | 24.36B | 28B |
| Receivables | 9.57B | 11.39B | 11.82B | 12.87B | 14.22B | 17.68B | 38.97B | 48.45B | 52.72B | 187.46B |
| Other Current Assets | 12.03B | 12.98B | 16.57B | 21.07B | 23.64B | 23.48B | 9.84B | 8.21B | 0 | 33.31B |
| Goodwill & Intangibles | 63.05B | 68.23B | 76.01B | 82.19B | 85.84B | 107.75B | 118.93B | 130B | 130.97B | 394.29B |
| Goodwill | 54.56B | 58.91B | 65.66B | 71.34B | 75.8B | 93.35B | 103.73B | 106.73B | 110.5B | 0 |
| Intangible Assets | 8.49B | 9.32B | 10.35B | 10.86B | 10.04B | 14.4B | 15.19B | 23.27B | 20.47B | 0 |
| PP&E (Net) | 7.01B | 8.46B | 8.7B | 8.63B | 8.97B | 10.13B | 11.45B | 10.55B | 10.76B | 0 |
| Other Assets | 1.39B | 81.02B | 94.05B | 102.33B | 107.33B | 12.26B | 64.91B | 19.59B | 23.01B | 164.73B |
| Total Liabilities | 87.03B | 95.99B | 111.73B | 126.75B | 135.73B | 159.36B | 174.8B | 195.69B | 207.88B | 207.32B |
| Total Debt | 31.69B | 36.55B | 40.68B | 43.47B | 46B | 57.62B | 67.44B | 76.9B | 78.39B | 77.92B |
| Net Debt | 19.71B | 25.69B | 29.69B | 26.55B | 24.63B | 34.26B | 42.01B | 51.59B | 54.02B | 49.92B |
| Long-Term Debt | 28.84B | 34.58B | 36.81B | 38.65B | 42.38B | 54.51B | 58.26B | 72.36B | 72.32B | 71.44B |
| Short-Term Debt | 2.86B | 1.97B | 3.87B | 4.82B | 3.62B | 3.11B | 5.31B | 4.54B | 6.07B | 6.48B |
| Total Current Liabilities | 50.46B | 53.21B | 61.78B | 72.42B | 78.29B | 89.24B | 99.05B | 103.77B | 114.9B | 114.12B |
| Accounts Payable | 33.05B | 36.6B | 40.7B | 44.37B | 49.13B | 56.77B | 31.96B | 68.56B | 38.03B | 39.66B |
| Deferred Revenue | 2.27B | 2.4B | 2.62B | 2.84B | 2.57B | 3.08B | 3.35B | 3.32B | 3.41B | 0 |
| Other Current Liabilities | 12.29B | 12.24B | 14.6B | 20.39B | 22.98B | 26.28B | 58.43B | 27.35B | 28.05B | 67.99B |
| Deferred Taxes | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 6.97B |
| Other Liabilities | 7.74B | 8.2B | 13.14B | 15.68B | 15.05B | 12.84B | 11.94B | 15.94B | 18.25B | 21.76B |
| Total Equity | 52.02B▲ 0% | 56.23B▲ 8.1% | 62.16B▲ 10.6% | 70.54B▲ 13.5% | 76.48B▲ 8.4% | 86.35B▲ 12.9% | 98.92B▲ 14.6% | 102.59B▲ 3.7% | 101.7B▼ 0.9% | 105.32B▲ 0% |
| Equity Growth % | 28.74% | 8.08% | 10.56% | 13.48% | 8.42% | 12.9% | 14.56% | 3.71% | -0.87% | 6.17% |
| Shareholders Equity | 49.83B | 51.7B | 57.62B | 65.49B | 71.76B | 77.77B | 88.76B | 92.66B | 94.11B | 103.89B |
| Minority Interest | 2.19B | 4.53B | 4.55B | 5.05B | 4.72B | 8.57B | 10.16B | 9.93B | 7.59B | 1.42B |
| Retained Earnings | 48.73B | 55.85B | 61.18B | 69.3B | 77.13B | 86.16B | 95.77B | 96.04B | 95.6B | 0 |
| Common Stock | 10M | 10M | 9M | 10M | 10M | 9M | 9M | 9M | 9M | 0 |
| Accumulated OCI | -2.67B | -4.16B | -3.58B | -3.81B | -5.38B | -8.39B | -7.03B | -3.39B | -2.06B | 0 |
| Return on Equity (ROE) | 22.85% | 22.15% | 23.38% | 23.21% | 23.51% | 24.71% | 24.16% | 14.3% | 11.8% | 11.54% |
| Return on Assets (ROA) | 8.07% | 8.23% | 8.49% | 8.3% | 8.44% | 8.79% | 8.62% | 5.04% | 3.97% | 3.87% |
| Equity / Assets | 37.41% | 36.94% | 35.75% | 35.75% | 36.04% | 35.14% | 36.14% | 34.39% | 32.85% | 33.69% |
| Debt / Equity | 0.61x | 0.65x | 0.65x | 0.62x | 0.60x | 0.67x | 0.68x | 0.75x | 0.77x | 0.77x |
| Book Value per Share | 52.81 | 57.20 | 64.35 | 73.40 | 80.00 | 90.89 | 105.46 | 110.43 | 111.76 | 115.74 |
| Tangible BV per Share | -11.19 | -12.22 | -14.33 | -12.13 | -9.79 | -22.53 | -21.33 | -29.51 | -32.17 | 115.74 |
UNH Cash Flow Statement
UnitedHealth Group Incorporated (UNH) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 13.6B | 15.71B | 18.46B | 22.17B | 22.34B | 26.21B | 29.07B | 24.2B | 19.7B | 19.7B |
| Operating CF Growth % | 38.81% | 15.57% | 17.5% | 20.1% | 0.76% | 17.29% | 10.92% | -16.73% | -18.62% | -40.7% |
| Operating CF / Revenue % | 6.76% | 6.95% | 7.62% | 8.62% | 7.77% | 8.08% | 7.82% | 6.05% | 4.4% | 4.38% |
| Net Income | 10.56B | 11.99B | 13.84B | 15.77B | 17.29B | 20.12B | 22.38B | 15.24B | 12.81B | 12.04B |
| Depreciation & Amortization | 2.25B | 2.43B | 2.72B | 2.89B | 3.1B | 3.4B | 3.97B | 4.1B | 4.36B | 4.33B |
| Stock-Based Compensation | 597M | 638M | 697M | 679M | 800M | 925M | 1.06B | 1.02B | 971M | 944M |
| Deferred Taxes | -748M | 42M | 230M | -60M | -814M | -673M | -245M | -296M | -989M | -817M |
| Other Non-Cash Items | 265M | 325M | 294M | 0 | 447M | 188M | 258M | 4.95B | 265M | 225M |
| Working Capital Changes | 679M | 294M | 683M | 2.9B | 1.52B | 2.25B | 1.64B | -808M | 2.28B | 5.66B |
| Cash from Investing | -8.6B | -12.38B | -12.7B | -12.53B | -10.37B | -28.48B | -15.57B | -20.53B | -8.69B | -10.89B |
| Capital Expenditures | -2.02B | -2.06B | -2.07B | -2.05B | -2.45B | -2.8B | -3.39B | -3.5B | -3.62B | -3.49B |
| Acquisitions | -2.13B | -6B | -8.34B | -7.14B | -4.82B | -21.46B | -10.14B | -13.41B | -4.51B | -3.81B |
| Purchase of Investments | -4.32B | -4.1B | -2.5B | -16.58B | -1.84B | -18.82B | -18.31B | -27.31B | 0 | 1.78B |
| Sale/Maturity of Investments | 10.27B | 9.91B | 15.63B | 13.74B | 15.3B | 11.99B | 16.54B | 27.83B | 361M | -4.99B |
| Other Investing | -10.39B | -10.14B | -15.41B | -506M | -16.55B | 2.62B | -275M | -4.14B | -915M | -386M |
| Cash from Financing | -3.44B | -4.37B | -5.63B | -3.59B | -7.46B | 4.23B | -11.53B | -3.51B | -11.64B | -14.73B |
| Dividends Paid | -2.77B | -3.32B | -3.93B | -4.58B | -5.28B | -5.99B | -6.76B | -7.53B | -7.92B | -8.01B |
| Share Repurchases | -1.5B | -4.5B | -5.5B | -4.25B | -5B | -7B | -8B | -9B | -5.54B | -2.54B |
| Stock Issued | 688M | 838M | 1.04B | 1.44B | 1.35B | 1.25B | 1.35B | 1.85B | 0 | -360M |
| Debt Issuance (Net) | -1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | -2M |
| Other Financing | 3.45B | -679M | -187M | 2.66B | 344M | 3.43B | -2.4B | -3.48B | 1.09B | -236M |
| Net Change in Cash | 1.55B▲ 0% | -1.11B▼ 171.9% | 119M▲ 110.7% | 5.94B▲ 4888.2% | 4.45B▼ 25.0% | 1.99B▼ 55.3% | 2.06B▲ 3.6% | -115M▼ 105.6% | 2.81B▲ 2542.6% | 1.07B▲ 0% |
| Exchange Rate Effect | -5M | -78M | -20M | -116M | -62M | 34M | 97M | -280M | 3.44B | 3.54B |
| Cash at Beginning | 10.43B | 11.98B | 10.87B | 10.98B | 16.92B | 21.38B | 23.36B | 25.43B | 25.31B | 24.36B |
| Cash at End | 11.98B | 10.87B | 10.98B | 16.92B | 21.38B | 23.36B | 25.43B | 25.31B | 28.12B | 28B |
| Free Cash Flow | 11.57B▲ 0% | 13.65B▲ 17.9% | 16.39B▲ 20.1% | 20.12B▲ 22.8% | 19.89B▼ 1.2% | 23.4B▲ 17.7% | 25.68B▲ 9.7% | 20.7B▼ 19.4% | 16.07B▼ 22.4% | 19.67B▲ 0% |
| FCF Growth % | 43.05% | 17.95% | 20.09% | 22.76% | -1.16% | 17.67% | 9.73% | -19.38% | -22.36% | -20.9% |
| FCF Margin % | 5.75% | 6.03% | 6.77% | 7.83% | 6.92% | 7.22% | 6.91% | 5.17% | 3.59% | 4.37% |
| FCF per Share | 11.75 | 13.89 | 16.97 | 20.94 | 20.8 | 24.64 | 27.38 | 22.29 | 17.66 | 17.66 |
UNH Key Ratios
UnitedHealth Group Incorporated (UNH) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 92.44% | 92.33% | 91.87% | 91.29% | 91.67% | 91.23% | 91.29% | 91.93% | 95.76% | 95.81% |
| Medical Cost Ratio | 76.63% | 76.2% | 76.21% | 73.94% | 75.78% | 75.44% | 75.52% | 77.67% | 81.47% | 81.2% |
| Return on Equity (ROE) | 22.85% | 22.15% | 23.38% | 23.21% | 23.51% | 24.71% | 24.16% | 14.3% | 11.8% | 11.54% |
| Return on Assets (ROA) | 8.07% | 8.23% | 8.49% | 8.3% | 8.44% | 8.79% | 8.62% | 5.04% | 3.97% | 3.87% |
| Equity / Assets | 37.41% | 36.94% | 35.75% | 35.75% | 36.04% | 35.14% | 36.14% | 34.39% | 32.85% | 33.69% |
| Book Value / Share | 52.81 | 57.2 | 64.35 | 73.4 | 80 | 90.89 | 105.46 | 110.43 | 111.76 | 115.74 |
| Debt / Equity | 0.61x | 0.65x | 0.65x | 0.62x | 0.60x | 0.67x | 0.68x | 0.75x | 0.77x | 0.77x |
| Revenue Growth | 8.83% | 12.47% | 7.03% | 6.19% | 11.84% | 12.71% | 14.64% | 7.71% | 11.81% | 9.67% |
UNH SEC Filings & Documents
UnitedHealth Group Incorporated (UNH) SEC filings — annual & quarterly reports (10-K, 10-Q)
UNH Frequently Asked Questions
UnitedHealth Group Incorporated (UNH) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
UnitedHealth Group Incorporated (UNH) grew revenue by 11.8% over the past year. This is steady growth.
Yes, UnitedHealth Group Incorporated (UNH) is profitable, generating $12.04B in net income for fiscal year 2025 (2.7% net margin).
Dividend & Returns
Yes, UnitedHealth Group Incorporated (UNH) pays a dividend with a yield of 2.39%. This makes it attractive for income-focused investors.
UnitedHealth Group Incorporated (UNH) has a return on equity (ROE) of 11.8%. This is reasonable for most industries.
Industry Metrics
UnitedHealth Group Incorporated (UNH) has a combined ratio of 95.8%. A ratio below 100% indicates underwriting profitability.
Explore More UNH
UnitedHealth Group Incorporated (UNH) financial analysis — history, returns, DCA and operating performance tools
Full UNH Stock Analysis
Analyst verdict, bull/bear case, risk factors and peer comparison
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates